pefloxacin has been researched along with Dysentery, Bacillary in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baribwira, C; Gendrel, D; Moreno, JL; Nduwimana, M; Raymond, J | 1 |
Biron, F; Boibieux, A; Peyramond, D; Tigaud, S | 1 |
Cassel-Beraud, AM; Gendrel, D; Guyon, P; Rakotonirina, G | 1 |
3 other study(ies) available for pefloxacin and Dysentery, Bacillary
Article | Year |
---|---|
One-dose treatment with pefloxacin for infection due to multidrug-resistant Shigella dysenteriae type 1 in Burundi.
Topics: Administration, Oral; Adolescent; Anti-Infective Agents; Burundi; Child; Child, Preschool; Drug Resistance, Microbial; Drug Resistance, Multiple; Dysentery, Bacillary; Feces; Follow-Up Studies; Humans; Infant; Pefloxacin; Shigella dysenteriae | 1997 |
[Treatment of salmonellosis and shigellosis with the new quinolones].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Ciprofloxacin; Dysentery, Bacillary; Female; Humans; Male; Middle Aged; Ofloxacin; Pefloxacin; Salmonella; Salmonella Infections; Shigella | 1990 |
Short-term pefloxacin therapy in Madagascan children with shigellosis due to multiresistant organisms.
Topics: 4-Quinolones; Anti-Infective Agents; Child; Child, Preschool; Disease Outbreaks; Drug Resistance, Multiple; Dysentery, Bacillary; Fluoroquinolones; Humans; Infant; Madagascar; Pefloxacin; Quinolones; Shigella dysenteriae | 1994 |